Latest Health News

Orora’s FY26 results reveal a $616.6 million statutory loss driven by a $742.8 million Glass impairment, offset by robust growth in its Cans business and disciplined capital management.

Amcor’s FY 2026 results highlight a dramatic boost from the Berry acquisition, with net sales soaring 57% to $23.5 billion and adjusted EBITDA up 68%. The company also raised its quarterly dividend and outlined a transition to a December year-end.

Bailador Technology Investments (ASX:BTI) posted a 64% drop in net profit to $6.9 million for FY26, amid a 55% fall in gains on financial assets. Despite this, the fund declared a fully franked 3.5 cent dividend and highlighted strong AI adoption and growth across its private tech portfolio.

HomeCo Daily Needs REIT reported a 44% jump in profit to $361.6 million for FY26, driven by strong property income and a $311 million portfolio valuation uplift. The REIT maintained stable distributions and upgraded its debt facilities with a BBB+ credit rating.

Vital Healthcare Property Trust (NZX:VHP) delivered a robust FY26, marked by a successful management internalisation, 23.5% AFFO growth, and a stable distribution payout, underpinning its position as a leading healthcare infrastructure owner in Australasia.

Pro Medicus’ US subsidiary Visage Imaging has landed a 7-year, A$23 million contract to deploy its cloud-based Visage 7 platform across St. Luke’s Health System, marking a further expansion in North America.

EBR Systems marked a commercial milestone with over 100 WiSE CRT implants and secured purchasing agreements with three major US healthcare networks. The company is progressing toward Medicare coverage and scaling manufacturing, supported by a near-complete A$150 million capital raise.

LTR Pharma reports a 93% response rate in men seeking convenience and spontaneity with SPONTAN, alongside a 64% response in post-prostatectomy patients, highlighting potential for its rapid-onset intranasal ED treatment in challenging populations.

Life360 has surged past 100 million monthly active users, posting record revenue and subscriber growth in Q2 2026. Its AI-driven platform and expanding advertising business underpin strong profitability and a confident outlook.

PGG Wrightson posted a robust FY26 with $1.1 billion revenue and a 46% jump in net profit, driven by strong livestock prices and strategic acquisitions.

Vection Technologies has locked in $1.2 million in non-repayable government funding to advance four distinct R&D projects spanning AI, Extended Reality, digital health, and inclusive technology.

Integral Diagnostics (ASX: IDX) posted strong preliminary FY26 results with revenue nearing $790 million and operating EBITDA up 30%, while announcing Jenny Martin as incoming CFO amid leadership transitions.